Sir, Platelet dysfunction, the use of heparin and antiplatelets increase the risk of gastrointestinal (GI) bleeding in chronic kidney disease (CKD) patients on dialysis. [1] We report an unusual cause of GI bleeding in a patient on hemodialysis.
A 66-year-old female, a known case of type 2 diabetes mellitus, hypertension, ischemic heart disease, and CKD presented to us with a history of fall 2 weeks back. During this fall, she sustained an injury to her back and left hand. Her evaluation revealed a normotensive afebrile woman with pedal edema and swelling in the left forearm. Her initial investigations [ Table 1 ] revealed the presence of severe renal failure, mild hypocalcemia, severe hyperphosphatemia, normal Vitamin D, and elevated serum parathormone levels. Her radiological investigations revealed a fracture of the left distal radius and 12 th thoracic vertebral fracture for which she underwent surgery. She was initiated on hemodialysis through a right internal jugular catheter, and for her hyperphosphatemia, she was started on sevelamer carbonate 800 mg three times a day with food.
On the 5 th postoperative day, she had melena with a significant drop in hemoglobin (12.0 g/dl to 8.6 g/dl). There was no history of abdominal pain vomiting or constipation. Her bleeding parameters were normal. An upper GI endoscopy showed mild gastric erosions. Her aspirin and clopidogrel were stopped. Next day, she had large quantity of maroon colored rectal bleed with further drop in hemoglobin (6.5 g/dl). A colonoscopy this time showed an ileocecal valve ulcer with active ooze. There were multiple erosions all over the colon. Colonic biopsies were taken and the active ulcer was photocoagulated. She received blood transfusions during dialysis. Her GI bleeding settled subsequently. At discharge, her hemoglobin was 9.8 g/dl.
Her colonic biopsy report came as extensive mucosal ulceration with areas of the organization and crystalloid structures [ Figure 1 ]. These rusty yellow colored crystals had slightly curved fish scale structure suggestive of sevelamer crystals. Her clinical and laboratory investigations for common causes of GI bleeding (infective, inflammatory, and neoplastic) were noncontributory. It was felt that sevelamer carbonate was responsible for the GI bleeding aggravated by the concomitant use of antiplatelet medications. Sevelamer carbonate was withdrawn, and calcium acetate was started. At discharge she is stable, and there was no recurrence of bleeding even after the reinstitution of aspirin and clopidogrel.
Recently, the use sevelamer carbonate is implicated in various gastrointestinal symptoms in CKD patients. [2] 
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Difficult Vascular Access in a Patient on Chronic Hemodialysis
Sir, Long-term chronic hemodialysis in patients with end-stage renal failure requires a durable vascular access. Patients with central venous catheters (CVCs) are prone for recurrent infections, vascular thrombosis, and vascular stenosis, which contribute to significant morbidity and mortality. We present a case of a 31-year-old male who had a transhepatic hemodialysis catheter lasting for 4.5 years.
We report a 31-year-old male who had been on renal replacement therapy for the past 15 years. The native kidney disease was reflux nephropathy progressing to end-stage renal failure. Peritoneal dialysis was started at the onset but had to be switched to hemodialysis due to recurrent peritonitis. Multiple attempts for arteriovenous fistula and grafts were unsuccessful. Prothrombotic workup was negative. Hence, the patient had been maintained on tunneled CVCs (internal jugular/subclavian and femoral access) for almost 12 years. Femoral access was 14 F × 24 cm permacath, and the tip was positioned within the left semi azygos vein. However, multiple vessel catheterization and instrumentation resulted in thrombosis of most of his accessible veins including iliac veins along with superior vena cava syndrome.
Computed tomographic angiography done showed multiple dilated vascular channels seen in the anterior abdominal wall, perihepatic, mesenteric, and retroperitoneal region, pelvis as well as in both groins. There was evidence of probable left axillary-iliac bypass, which was thrombosed [ Figure 1 ].
Ultimately, he required a transhepatic vascular access, which was inserted in September 2012. SplitCath III-Medcomp permacath 14 F × 28 cm was used and catheter tip was confirmed in inferior vena cava (IVC).
The hepatic route was chosen over translumbar route in view of higher risk of complications encountered with translumbar approaches such as bleeding secondary to injury to right renal artery or its aberrant branches, kinks. Transrenal route, although described, is not used as renal veins are not desirable in patients with kidney disease. Transfemoral catheter is usually inserted for short-term use and may not be very suitable for patients on chronic hemodialysis.
